Lasa Supergenerics Ltd
Lasa Supergenerics Ltd Share Price Today: Live Updates & Key Insights
Get insights on Lasa Supergenerics Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Lasa Supergenerics Ltd Share Price Chart
Lasa Supergenerics Ltd Fundamentals
Traded Volume: 18,477
Market Cap(Cr): 53
Avg Traded Price 44.10
1 Year return -60.44%
Upper Circuit 10.9
Lower Circuit 10.4
P/E TTM -2.00
P/B Ratio -7.00
Traded Value(Cr) 1.96
EPS TTM -6.616
Book value -6.616
Dividend 0.00%
Lasa Supergenerics Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Lasa Supergenerics Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Lasa Supergenerics Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -7.82%
1M -1.76%
3M +4.12%
1Y -60.44%
YTD -60.09%
Lasa Supergenerics Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Lasa Supergenerics Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 37608.00
Day Before Yesterday 30719.00
1W Avg 30412.00
1M Avg 42901.05
3M Avg 1.47L
Lasa Supergenerics Ltd Technical Details
Lasa Supergenerics Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 10
Support 2 10
Support 3 10
Pivot Point : 11
Resistance 1 11
Resistance 2 11
Resistance 3 11
Lasa Supergenerics Ltd Corporate Actions
Lasa Supergenerics Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Lasa Supergenerics Ltd’s capital allocation strategies.
All
Ex-Date 16-Sep-2022 Type D Description 0.25/share@2.50% Record Date 19-Sep-2022 Ratio 2.50
Ex-Date 15-Sep-2021 Type D Description 0.25/share@2.50% Record Date 13-Nov-2025 Ratio 2.50
Dividends
Announcement Date 16-Sep-2022 Ex Dividend Date 16-Sep-2022 Dividend(%) 3
Announcement Date 15-Sep-2021 Ex Dividend Date 15-Sep-2021 Dividend(%) 3
Bonus
No Bonus has been declared by LASA
Splits
No Split has been declared by LASA
Others
Rights No Rights has been declared by LASA
Lasa Supergenerics Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Lasa Supergenerics Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Lasa Supergenerics Ltd's relative performance and valuation against major competitors.
Stock Name Godavari Drugs Ltd ₹84.00 (+0.47%) M. Cap (Cr) 0.63 1 Yr Return (%) -32.15% P/E (TTM) 16.69 PB Ratio 1.46
Stock Name Shelter Pharma Ltd ₹41.25 (-1.93%) M. Cap (Cr) 0.61 1 Yr Return (%) -24.99% P/E (TTM) 8.47 PB Ratio 1.33
Stock Name Vista Pharmaceuticals Ltd ₹9.15 (-4.09%) M. Cap (Cr) 0.56 1 Yr Return (%) -27.38% P/E (TTM) -11.08 PB Ratio 1.24
Stock Name Lasa Supergenerics Ltd ₹10.61 (-0.66%) M. Cap (Cr) 0.53 1 Yr Return (%) -60.44% P/E (TTM) -1.60 PB Ratio 0.63
Stock Name Vasundhara Rasayans Ltd ₹163.20 (-1.60%) M. Cap (Cr) 0.52 1 Yr Return (%) -42.14% P/E (TTM) 13.17 PB Ratio 1.46
Stock Name Kabra Drugs Ltd ₹21.72 (+4.98%) M. Cap (Cr) 0.51 1 Yr Return (%) +126.49% P/E (TTM) -49.52 PB Ratio 2.09
Stock Name Medi Caps Ltd ₹38.50 (-1.66%) M. Cap (Cr) 0.48 1 Yr Return (%) -25.10% P/E (TTM) -8.51 PB Ratio 0.39
Lasa Supergenerics Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Lasa Supergenerics Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 -2.82 Mar 2024 2.14 Mar 2023 -17.30 Mar 2022 10.49 Mar 2021 41.31
PARTICULARS Investing Activities Mar 2025 8.15 Mar 2024 -0.40 Mar 2023 11.19 Mar 2022 -3.25 Mar 2021 -3.60
PARTICULARS Financing Activities Mar 2025 -5.66 Mar 2024 -1.93 Mar 2023 -4.16 Mar 2022 -0.04 Mar 2021 -36.44
PARTICULARS Net Cash Flow Mar 2025 -0.33 Mar 2024 -0.19 Mar 2023 -10.27 Mar 2022 7.20 Mar 2021 1.27
Lasa Supergenerics Ltd Shareholding Pattern
This shows the ownership breakdown of Lasa Supergenerics Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 53.65%
Public 46.35%
Other Institutions 0%
FII null%
Mutual Funds null%
About Lasa Supergenerics Ltd
Lasa Supergenerics Limited was incorporated on March 11, 2016. The Company is primarily engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc. The Company is a vertically integrated group spanning the entire veterinary, animal and human healthcare value chain-from discovery-to-delivery, with established credentials in research, manufacturing and global marketing. The Company is a veterinary API manufacturing entity, which was acquired in April, 2012. The manufacturing facility is located at Mahad & Chiplun, in the Konkan region of Maharashtra. It specialises in `catalyst chemistry' and manufactures anthelmintic / veterinary API products with largest production capabilities and product categories in India. To efficiently control the supply chain, the Company is fully backward integrated for its key molecules-from discovery research up to full-scale bulk production. The Company's marketing footprint is entrenched across developing markets in multiple countries. Similarly, the group expects to augment its export footprint significantly in width and depth in the future.The Company announced the launching of 2 new block buster products with all-time strong segment, Oxycozanide. Oxyclozanide is an anthelmintic, used in the treatment and control of fascioliasis a topical worm infection in ruminants mainly domestic animals such as cattle, especially buffalos in farm, sheep, and goats. For this, the Company is setting up capacity in a brown field expansion at its Chiplun unit with a total capacity of 20 MT. It has got huge demand all over the globe as it is manufactured and have strong entry barriers. Likewise, this product fits in product selection criteria, through which the Company is confident of grabbing significant market share.The Scheme of Amalgamation of Harishree Aromatics and Chemicals Private Limited with the Company and their respective shareholders was approved by Hon'ble National Company Law Tribunal on December 23, 2022 which became effective from January 04, 2023 in year 2022-23. Following the said Scheme of Amalgamation, 1000 Equity Shares of Rs 10/- per share of the Company was allotted for every 35 Equity Shares of Rs 10/- of Harishree Aromatics and Chemicals Private Limited on January 5, 2023. The company received WHO Certificate of Good Manufacturing Practices from the Food and Drug Administration authorities for its manufacturing facility situated at Khed, Ratnagiri. The Company has alliances with leading Indian and global animal health care conglomerates and uses Good Manufacturing Practice (GMP) and world-class technologies in its operations. The Company is managed by a consortium of technocrats, including its Chairman and Managing Director Mr. Omkar P. Herlekar who are impelled by passion and propelled by niche innovation. The leadership team, which is guided by these values, is well positioned to lead into the future.
Chairman & Managing Director
Omkar P Herlekar
Registered office C-105 MIDC, Mahad, Raigad, Maharashtra, 402301
FAX :91-2145-232101/232202
Background
Incorporation Year 2016
Face Value ₹10.00
Market Lot 1
FAQs on Lasa Supergenerics Ltd
How to buy Lasa Supergenerics Ltd shares on NSE?
To buy Lasa Supergenerics Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Lasa Supergenerics Ltd share price today?
The Lasa Supergenerics Ltd share price on NSE is ₹10.61 today.
What is the market cap of Lasa Supergenerics Ltd on NSE?
The company has a market capitalization of ₹53.16.
What is the PE & PB ratio of Lasa Supergenerics Ltd?
PE is -2 and PB is -7.
What is the 52 Week High and Low of Lasa Supergenerics Ltd shares?
Lasa Supergenerics Ltd stock price high: ₹31.40 Lasa Supergenerics Ltd stock price low: ₹8.16.